Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Case Report Investigates Possible Connection Between mRNA COVID-19 Vaccines and Cancer

February 12, 2026
Continue Reading
case-report-investigates-possible-connection-between-mrna-covid-19-vaccines-and-cancer
Posted inBiotechnology

New Diabetes Medication Shows Promise in Reducing Eye Disease Risk

February 12, 2026
Continue Reading
new-diabetes-medication-shows-promise-in-reducing-eye-disease-risk
Posted inBiotechnology

Impact of Activity on Older Adults’ Health and Falls

February 12, 2026
Continue Reading
impact-of-activity-on-older-adults’-health-and-falls
Posted inBiotechnology

Can Language Models Accurately Judge Empathy?

February 12, 2026
Continue Reading
can-language-models-accurately-judge-empathy?
Posted inBiotechnology

ASH Releases Clinical Practice Guidelines for Frontline and Relapsed/Refractory Management in Adolescents and Young Adults

February 12, 2026
Continue Reading
ash-releases-clinical-practice-guidelines-for-frontline-and-relapsed/refractory-management-in-adolescents-and-young-adults
Posted inBiotechnology

Cardiovascular Disease Models: Heart and Vasculature-on-a-Chip

February 12, 2026
Continue Reading
cardiovascular-disease-models:-heart-and-vasculature-on-a-chip
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

ai-expedites-motor-neuron-analysis-and-screening-in-als-research
Posted inGenetics

AI Expedites Motor Neuron Analysis and Screening in ALS Research

December 20, 2024
Developing motor neurons from stem cells taken directly from amyotrophic lateral sclerosis (ALS) patients offers new hope for better understanding…
Read More
fda-rejects-zealand-pharma’s-glp-2-analog-in-rare-bowel-disease
Posted inBiotechnology

FDA rejects Zealand Pharma’s GLP-2 analog in rare bowel disease

December 19, 2024
The FDA has denied Zealand Pharma’s approval bid for glepaglutide—a possible challenger to Takeda’s Gattex—in short bowel syndrome (SBS), citing…
Read More
flu-vaccine-response-boosted-by-coupling-antigens-from-multiple-subtypes
Posted inGenetics

Flu Vaccine Response Boosted by Coupling Antigens from Multiple Subtypes

December 19, 2024
The seasonal influenza vaccine contains strains of viruses from distinct virus subtypes, but most people who are vaccinated will mount…
Read More
pyxis-oncology-shelves-antibody-to-focus-on-sole-clinical-asset,-an-adc-licensed-from-pfizer
Posted inBiotechnology

Pyxis Oncology shelves antibody to focus on sole clinical asset, an ADC licensed from Pfizer

December 19, 2024
Pyxis Oncology is shelving a clinical-stage monoclonal antibody to focus on its lead antibody-drug conjugate (ADC) after sharing preliminary results…
Read More
oncology-biotech-epitopea-licenses-genevant-nucleic-acid-delivery-tech-for-up-to-$123m
Posted inBiotechnology

Oncology biotech Epitopea licenses Genevant nucleic acid delivery tech for up to $123M

December 19, 2024
To develop RNA medicines targeting a proprietary bundle of tumor antigens, Epitopea is tapping nucleic acid delivery specialist Genevant Sciences…
Read More
chutes-&-ladders—fda’s-principal-deputy-to-depart-agency
Posted inBiotechnology

Chutes & Ladders—FDA’s principal deputy to depart agency

December 19, 2024
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please…
Read More
omeros-antibody-improves-overall-survival-by-68%-in-rare-condition,-new-analysis-finds
Posted inBiotechnology

Omeros antibody improves overall survival by 68% in rare condition, new analysis finds

December 19, 2024
Omeros is putting up its monoclonal antibody up for FDA approval—again. This time, the resubmission will be based on a…
Read More
merck’s-hiv-combo-treatment-meets-the-bar-for-viral-suppression-in-pair-of-phase-3-studies
Posted inBiotechnology

Merck’s HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies

December 19, 2024
After hitting the mark in a phase 2 of its investigational islatravir paired with Gilead’s lenacapivir, Merck & Co.'s islatravir…
Read More
vc-firm-pens-$608m-biobucks-deal-to-redirect-ngm’s-mash-drug-to-rare-disease
Posted inBiotechnology

VC firm pens $608M biobucks deal to redirect NGM’s MASH drug to rare disease

December 19, 2024
KdT Ventures has signed off on a $608 million biobucks deal for NGM Biopharmaceuticals’ phase 2-ready metabolic-dysfunction associated steatohepatitis (MASH)…
Read More
scinai-immunotherapeutics-establishes-us.-cdmo-subsidiary
Posted inGenetics

Scinai Immunotherapeutics Establishes U.S. CDMO Subsidiary

December 19, 2024
Scinai Immunotherapeutics, which focuses on developing inflammation and immunology biological products and providing CDMO services through its Scinai Bioservices business…
Read More

Posts pagination

Previous page 1 … 1,395 1,396 1,397 1,398 1,399 … 1,410 Next page
You May Have Missed
ge-healthcare-debuts-tech-to-help-hospitals-remotely-maintain-bedside-ecg-stations
Posted inMedical Technology

GE HealthCare debuts tech to help hospitals remotely maintain bedside ECG stations

merck-teams-up-with-british-medtech-to-boost-vaginal-therapeutics-delivery-system
Posted inMedical Technology

Merck teams up with British medtech to boost vaginal therapeutics delivery system

fda-slaps-highest-risk-recall-notice-on-j&j-medtech-cerepak-detachable-coils
Posted inMedical Technology

FDA slaps highest-risk recall notice on J&J Medtech Cerepak detachable coils

qiagen-‘open-for-discussion’-on-shareholder-value,-but-ceo-stays-mum-on-takeover-talk
Posted inMedical Technology

Qiagen ‘open for discussion’ on shareholder value, but CEO stays mum on takeover talk

Privacy Policy    Terms

Scroll to Top